Impact of lung and heart immaturity when investigating medicinal products intended for neonatal use - Scientific guideline

This document specifically discusses the impact of lung and heart immaturity when investigating medicinal products in term and preterm newborns and infants.

Keywords: Neonates, medicines, drugs, developmental pharmacology, adreno-receptors, immaturity, lung, heart, surfactant

Current version

Draft concept paper on the impact of lung and heart immaturity when investigating medicinal products intended for neonatal use

Draft: consultation closed Reference Number: EMEA/CHMP/114218/2006